Back to Search
Start Over
Biological markers of disease activity in inflammatory bowel diseases
- Source :
- Gastroenterology Review, Vol 18, Iss 2, Pp 141-147 (2023)
- Publication Year :
- 2023
- Publisher :
- Termedia Publishing House, 2023.
-
Abstract
- Inflammatory bowel diseases (IBD) are chronic intestinal conditions of multifactorial aetiology including genetic susceptibility, immunological impairment, dysbiosis, and environmental factors. The diagnosis is based on both clinical and endoscopic features, wherein histopathological evaluation remains a gold diagnostic standard. However, fast, reliable, and non-invasive biological markers have been used for years for diagnosis as well as for disease activity monitoring. Currently, commonly used faecal calprotectin is the only biomarker approved and recommended by the European Crohn’s and Colitis Organization (ECCO). Nonetheless, other biological markers discriminating between functional and organic bowel conditions have been widely studied. Therefore, the aim of this manuscript was to review new potential biomarkers of inflammation in IBD. The aim of this study was to review currently available biomarkers of intestinal inflammation and increased gut permeability in IBD.
Details
- Language :
- English
- ISSN :
- 18955770 and 18974317
- Volume :
- 18
- Issue :
- 2
- Database :
- Directory of Open Access Journals
- Journal :
- Gastroenterology Review
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.f9016219844aaa9190fa2b504cfa34
- Document Type :
- article
- Full Text :
- https://doi.org/10.5114/pg.2023.129412